NDC 59368-037 - Jentadueto
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-037
- Package NDCs from labels
- 59368-037-60, 59368-037-18
- Manufacturer
- Praxis, LLC | Sixarp, LLC
- Effective date
- 2024-07-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Jentadueto - Praxis, LLC | Sixarp, LLC | Praxis, LLC | Sixarp, LLC | 2024-07-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f43c087a-7135-4a79-8463-fe5e9319da91 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 75b25738-31e6-4b58-9d2b-f4a1ab4ab090 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | Bionpharma Inc., | 3ab005d4-bc99-4fdb-e063-6394a90a5124 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Method Pharmaceuticals, LLC. | 4aa880a4-7ec0-9155-e063-6394a90a8f3e | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | d87dade1-55fe-4e77-91b9-b642022a2b8a | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 239834b0-121a-4903-b3ee-90bb4db4753b | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 5f2023d2-05ae-489d-9e18-fb75057496bc | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 1d7556eb-82b4-4085-b0b1-dc061b216feb | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Quallent Pharmaceuticals Health LLC | 6864ff5a-7512-4a4f-ad26-b2b9c5843414 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 8c248958-6c01-455e-89f5-959facb272ed | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 192970d3-826a-4b69-a525-9742794dc19c | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc | dfac4d9c-2f20-417c-a1be-4f1c2738f351 | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | a0ff8ee6-0da8-40f8-b5b0-a7b334e1a15f | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 273d86b0-9d30-48c9-8918-c5e1ececa951 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyxambi | EMPAGLIFLOZIN AND LINAGLIPTIN | Boehringer Ingelheim Pharmaceuticals, Inc. | ddbab689-f76c-488c-9613-4168d41dd730 | 2026-01-20 | Warnings, Adverse reactions | 3X29ZEJ4R2 |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 64650d2c-2bec-4470-b250-29d01caa1ebe | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ca71c133-6c38-4b9e-80af-1949634157f4 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| metformin hydrochloride | METFORMIN HYDROCHLORIDE TABLETS | EPIC PHARMA, LLC | 356b02d0-d239-4441-bb33-c4c54166fcd7 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 486fec17-ff83-3bab-e063-6394a90a5ef0 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e3e9b582-fd15-4fe0-a210-398d9149696e | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.